Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation

NCT03076151 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Transplantation
Kidney
Pharmacokinetic

Interventions

DRUG: Tacrolimus monohydrate (ADOPORT®)

Sponsor

University Hospital, Limoges